-The Hindu Draft Cabinet note on NIB not sent to me, he says Infrastructure projects that come up on forest land must comply with the Forest Rights Act (FRA), Union Tribal Affairs Minister Kishore Chandra Deo has said. No land in a Fifth Schedule area should be handed over to any industry if it violated the Panchayat (Extension to Scheduled Areas) Act (PESA), Mr. Deo said, responding to a query whether he agreed...

-The Times of India After Robert Vadra, it now seems to be the turn of his vociferous defender — Union law minister Salman Khurshid — to be in activist Arvind Kejriwal's crosshairs. Kejriwal on Wednesday demanded Khurshid's resignation following allegations of financial irregularities to the tune of Rs 71 lakh by a trust run for the welfare of the physically challenged. A TV channel had alleged that Zakir Hussain Memorial Trust, headed...

-The Indian Express The government’s proposal to price-control certain drugs will create more problems than it will solve From clothes to cars, prices of consumer products the world over are determined taking into account input costs, margins and competition, popularly called the cost-based pricing system. Departing from this sound, fair, tried and tested principle of commerce, the government’s new drug pricing policy, approved by the Group of Ministers headed by Sharad Pawar,...

-The Times of India GURGAON: US retail giant Walmart is planning a series of partnerships with small and mid-level suppliers in India across product categories to create a big list of private label brands that will be priced substantially lower - as much as 10-15% - than established products and brands. The move is part of the company's strategy to go deeper into the Indian market and create cost-effective and efficient...

-Live Mint The first in a two-part series examining the opaque world of clinical trials in India  A hospital in Indore has been able to get away with unethical medical trials in which 32 people have died over five years, according to the state government. This despite several investigations, a state government ban and Supreme Court strictures—a classic example of the lawless nature of the clinical trial business in India.   Lata Mehra, who...